Artificial reproductive techniques in multiple sclerosis

Clinical Immunology

Volumn 149, Issue 2, 2013, Pages 219-224

  Hellwig, Kerstin ^a   Correale, Jorge ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b FLENI   (Argentina)

Author keywords

Assisted reproductive treatment; Autoimmunity; Hormones; In vitro fertilization; Multiple sclerosis

Indexed keywords

CLOMIFENE; CYTOKINE; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; INTERLEUKIN 12; INTERLEUKIN 8; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; DISEASE ACTIVITY; DISEASE COURSE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GONADOTROPIN RELEASE; HUMAN; HYPOPHYSIS; IMMUNOCOMPETENT CELL; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LUTEAL PHASE; MIGRATION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY HYPERSTIMULATION; PRIORITY JOURNAL;

EID: 84885956665     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.02.001     Document Type: Review

References (29)

1. Cavalla P., Rovei V., Masera S., Vercellino M., Massobrio M., Mutani R., et al. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol. Sci. 2006, 27(4):231-239.
2. Jalkanen A., Alanen A., Airas L. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult. Scler. 2010, 16(8):950-955.
3. Grinsted L., Heltberg A., Hagen C., Djursing H. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J. Intern. Med. 1989, 226(4):241-244.
4. Lombardi G., Celso M., Bartelli M., Cilotti A., Del Popolo G. Female sexual dysfunction and hormonal status in multiple sclerosis patients. J. Sex. Med. 2011, 8(4):1138-1146.
5. Sloka J.S., Phillips P.W., Stefanelli M., Joyce C. Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort. J. Autoimmune Dis. 2005, 2:9.
6. Marrie R.A., Yu B.N., Leung S., Elliott L., Warren S., Wolfson C., et al. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data. Neuroepidemiology 2012, 39(2):135-142.
7. Demirkiran M., Sarica Y., Uguz S., Yerdelen D., Aslan K. Multiple sclerosis patients with and without sexual dysfunction: are there any differences?. Mult. Scler. 2006, 12(2):209-214.
8. Gnoth C., Godehardt E., Frank-Herrmann P., Friol K., Tigges J., Freundl G. Definition and prevalence of subfertility and infertility. Hum. Reprod. 2005, 20(5):1144-1147.
9. Hrometz S.L., Gates V.A. Review of available infertility treatments. Drugs Today (Barc.) 2009, 45(4):275-291.
10. Al-Inany H.G., Youssef M.A., Aboulghar M., Broekmans F., Sterrenburg M., Smit J., et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst. Rev. 2011, 5:CD001750.
11. Willis M.Y., Browne A.S., Session D.R., Spencer J.B. Controlled ovarian hyperstimulation: a review for the non-ART patient. Minerva Ginecol. 2011, 63(2):119-135.
12. Hellwig K., Beste C., Brune N., Haghikia A., Muller T., Schimrigk S., et al. Increased MS relapse rate during assisted reproduction technique. J. Neurol. 2008, 255(4):592-593.
13. Hellwig K., Schimrigk S., Beste C., Muller T., Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur. Neurol. 2009, 61(2):65-68.
14. Laplaud D.A., Leray E., Barriere P., Wiertlewski S., Moreau T. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006, 66(8):1280-1281.
15. Michel L., Foucher Y., Vukusic S., Confavreux C., de Seze J., Brassat D., et al. Increased risk of multiple sclerosis relapse after in vitro fertilisation. J. Neurol. Neurosurg. Psychiatry 2012, 83(8):796-802.
16. Correale J., Farez M.F., Ysrraelit M.C. Increase in multiple sclerosis activity after assisted reproduction technology. Ann. Neurol. 2012, 72(5):682-694.
17. Voskuhl R.R., Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 2001, 7(3):258-270.
18. Gold S.M., Voskuhl R.R. Estrogen and testosterone therapies in multiple sclerosis. Prog. Brain Res. 2009, 175:239-251.
19. Voskuhl R.R., Gold S.M. Sex-related factors in multiple sclerosis susceptibility and progression. Nat. Rev. Neurol. 2012, 8(5):255-263.
20. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 1998, 339(5):285-291.
21. Hellwig K., Haghikia A., Rockhoff M., Gold R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther. Adv. Neurol. Disord. 2012, 5(5):247-253.
22. Heesen C., Gold S.M., Huitinga I., Reul J.M. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review. Psychoneuroendocrinology 2007, 32(6):604-618.
23. Gold S.M., Mohr D.C., Huitinga I., Flachenecker P., Sternberg E.M., Heesen C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol. 2005, 26(12):644-652.
24. Pasch L.A., Gregorich S.E., Katz P.K., Millstein S.G., Nachtigall R.D., Bleil M.E., et al. Psychological distress and in vitro fertilization outcome. Fertil. Steril. 2012, 98(2):459-464.
25. Gonzalez D.A., Diaz B.B., Rodriguez Perez Mdel C., Hernandez A.G., Chico B.N., de Leon A.C. Sex hormones and autoimmunity. Immunol. Lett. 2010, 133(1):6-13.
26. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28(5):521-574.
27. Langer-Gould A., Gupta R., Huang S., Hagan A., Atkuri K., Leimpeter A.D., et al. Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis. Arch. Neurol. 2010, 67(1):51-57.
28. Chen H.F., Jeung E.B., Stephenson M., Leung P.C. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J. Clin. Endocrinol. Metab. 1999, 84(2):743-750.
29. Al-Inany H.G., Youssef M.A., Aboulghar M., Broekmans F., Sterrenburg M., Smit J., et al. GnRH antagonists are safer than agonists: an update of a Cochrane review. Hum. Reprod. Update 2011, 17(4):435.